PRMT1 Sustains <i>De Novo</i> Fatty Acid Synthesis by Methylating PHGDH to Drive Chemoresistance in Triple-Negative Breast CancerTakehiro Yamamoto, Makoto Suematsu, Tetsu Hayashida et al.|Cancer Research|2024Cited by 56
Clinical significance of ERG rearrangement subtype and its association with increased p53 expression in Japanese and German prostate cancerJ. Nishijima, Hideyasu Matsuyama, Takahito Hara et al.|Neoplasma|2015Cited by 10
Supplementary Fig.S4 from PRMT1 Sustains <i>De Novo</i> Fatty Acid Synthesis by Methylating PHGDH to Drive Chemoresistance in Triple-Negative Breast CancerTakehiro Yamamoto, Makoto Suematsu, Tetsu Hayashida et al.|Unknown|2024Cited by 0
Supplementary Fig.S8 from PRMT1 Sustains <i>De Novo</i> Fatty Acid Synthesis by Methylating PHGDH to Drive Chemoresistance in Triple-Negative Breast CancerTakehiro Yamamoto, Makoto Suematsu, Tetsu Hayashida et al.|Unknown|2024Cited by 0
Supplementary Fig.S12 from PRMT1 Sustains <i>De Novo</i> Fatty Acid Synthesis by Methylating PHGDH to Drive Chemoresistance in Triple-Negative Breast CancerTakehiro Yamamoto, Makoto Suematsu, Tetsu Hayashida et al.|Unknown|2024Cited by 0